The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 03, 2017

Filed:

Apr. 24, 2013
Applicant:

Ea Pharma Co., Ltd., Tokyo, JP;

Inventors:

Hirokazu Ueno, Kawasaki, JP;

Takashi Yamamoto, Kawasaki, JP;

Ryuta Takashita, Kawasaki, JP;

Ryohei Yokoyama, Kawasaki, JP;

Toshihiko Sugiura, Kawasaki, JP;

Shunsuke Kageyama, Kawasaki, JP;

Ayatoshi Ando, Kawasaki, JP;

Hiroyuki Eda, Kawasaki, JP;

Agung Eviryanti, Kawasaki, JP;

Tomoko Miyazawa, Kawasaki, JP;

Aya Kirihara, Kawasaki, JP;

Itsuya Tanabe, Kawasaki, JP;

Tarou Nakamura, Kawasaki, JP;

Misato Noguchi, Kawasaki, JP;

Manami Shuto, Kawasaki, JP;

Masayuki Sugiki, Kawasaki, JP;

Mizuki Dohi, Kawasaki, JP;

Assignee:

EA Pharma Co., Ltd., Tokyo, JP;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 471/04 (2006.01); C07D 403/12 (2006.01); C07D 401/14 (2006.01); C07D 405/12 (2006.01); C07D 239/54 (2006.01); C07D 473/04 (2006.01); C07D 401/12 (2006.01); C07D 239/36 (2006.01); A61P 29/00 (2006.01);
U.S. Cl.
CPC ...
C07D 471/04 (2013.01); C07D 239/36 (2013.01); C07D 239/54 (2013.01); C07D 401/12 (2013.01); C07D 401/14 (2013.01); C07D 403/12 (2013.01); C07D 405/12 (2013.01); C07D 473/04 (2013.01);
Abstract

Sulfonamide compounds of a specific chemical structure in which a sulfonamide group having, as a substituent, a phenyl group or a heterocyclic group having a hetero atom(s) as a constituent element(s) is present at its terminal, and pharmaceutically acceptable salts thereof. These compounds are novel compounds having excellent α4 integrin-inhibitory action. The compounds have formulae represented by:


Find Patent Forward Citations

Loading…